• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒(HPV)感染性上皮内瘤样病变中肠道来源的上皮内淋巴细胞(IEL)的特征。

Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.

机构信息

Faculty of Medicine, Department of Obstetrics and Gynecology, University of Tokyo, Hongo, Bunkyo-ku, Japan.

出版信息

Am J Reprod Immunol. 2011 Nov;66(5):435-43. doi: 10.1111/j.1600-0897.2011.01041.x. Epub 2011 Jul 12.

DOI:10.1111/j.1600-0897.2011.01041.x
PMID:21749545
Abstract

PROBLEM

Mucosal T cells are the most likely direct effectors in host anti-human papillomavirus adaptive immunity and regression of cervical intraepithelial neoplasia (CIN) lesions. There are no studies addressing intraepithelial lymphocytes (IELs) in CIN lesions.

METHOD OF STUDY

Cervical lymphocytes were collected using cytobrushes from patients with CIN and analyzed by FACS analysis. Comparisons were made between populations of cervical T cells in CIN regressors and non-regressors.

RESULTS

A median of 74% of cervical lymphocytes were CD3(+) T cells. Populations of integrin αEβ7(+) IEL in CIN lesions varied markedly among patients (6-57%). Approximately half of integrin β7(+) T cells were CD45RA-negative memory T cells. The number of integrin αEβ7(+) cells among cervical T cells was significantly higher in CIN regressors when compared to non-regressors.

CONCLUSION

Higher cervical IEL numbers are associated with spontaneous regression of CIN. Accumulation of cervical integrin αEβ7(+) IEL may be necessary for local adaptive effector functions.

摘要

问题

黏膜 T 细胞是宿主抗人乳头瘤病毒适应性免疫以及宫颈上皮内瘤变(CIN)消退的最直接效应细胞。目前还没有研究涉及 CIN 病变中的上皮内淋巴细胞(IEL)。

方法

使用细胞刷从 CIN 患者中收集宫颈淋巴细胞,并通过 FACS 分析进行分析。比较 CIN 消退者和非消退者宫颈 T 细胞群体。

结果

中位数为 74%的宫颈淋巴细胞为 CD3(+) T 细胞。CIN 病变中整合素 αEβ7(+) IEL 的群体在患者之间差异很大(6-57%)。大约一半的整合素 β7(+) T 细胞为 CD45RA 阴性记忆 T 细胞。与非消退者相比,CIN 消退者宫颈 T 细胞中的整合素 αEβ7(+)细胞数量明显更高。

结论

更高的宫颈 IEL 数量与 CIN 的自发消退有关。宫颈整合素 αEβ7(+) IEL 的积累可能是局部适应性效应功能所必需的。

相似文献

1
Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.人乳头瘤病毒(HPV)感染性上皮内瘤样病变中肠道来源的上皮内淋巴细胞(IEL)的特征。
Am J Reprod Immunol. 2011 Nov;66(5):435-43. doi: 10.1111/j.1600-0897.2011.01041.x. Epub 2011 Jul 12.
2
The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN.HPV 相关的宫颈上皮内瘤变(CIN)中宫颈调节性 T 细胞的流行率与 CIN 的自发消退呈负相关。
Am J Reprod Immunol. 2013 Feb;69(2):134-41. doi: 10.1111/aji.12030. Epub 2012 Oct 11.
3
Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.程序性死亡(PD)-1及其配体 PD-L1 的表达增加与高危型人乳头瘤病毒相关的宫颈上皮内瘤变中的细胞介导免疫受损相关。
Immunology. 2013 Aug;139(4):513-22. doi: 10.1111/imm.12101.
4
Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.在持续性高危型人乳头瘤病毒感染的高级别宫颈上皮内瘤变中,产生干扰素-γ增加的不变自然杀伤T细胞的积累。
Diagn Pathol. 2015 Apr 2;10:20. doi: 10.1186/s13000-015-0254-8.
5
Flow Cytometry Characterization of Pluripotent Transmembrane Glycoproteins on Resident Cervix Uteri Cells in Patients Screened for Cervical Cancer.流式细胞术分析筛查宫颈癌患者宫颈固有细胞表面多能跨膜糖蛋白标志物
Cancer Invest. 2020 Apr;38(4):228-239. doi: 10.1080/07357907.2020.1742349. Epub 2020 Apr 13.
6
A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.在宫颈癌发生过程中向外周Th2型细胞因子模式的转变在CIN III病变中表现出来。
J Clin Pathol. 2005 Oct;58(10):1096-100. doi: 10.1136/jcp.2004.025072.
7
Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.人乳头瘤病毒疫苗接种年轻女性宫颈发育不良中的人乳头瘤病毒类型:基于人群的巢式病例对照研究。
Int J Cancer. 2020 May 1;146(9):2539-2546. doi: 10.1002/ijc.32848. Epub 2020 Jan 24.
8
The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.宫颈上皮内瘤变患者宫颈与肛门 HPV 感染的关系。
J Clin Virol. 2014 Jan;59(1):18-23. doi: 10.1016/j.jcv.2013.11.004. Epub 2013 Nov 23.
9
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.一项针对宫颈上皮内瘤变女性的队列研究中针对16型人乳头瘤病毒(HPV)病毒样颗粒的免疫反应。I. 与HPV感染及疾病转归相关的T辅助细胞和IgG反应差异
J Gen Virol. 1999 Feb;80 ( Pt 2):399-408. doi: 10.1099/0022-1317-80-2-399.
10
Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.红色诺卡氏菌细胞壁骨架上调T细胞亚群并抑制PD-1/PD-L1通路,以促进高危型人乳头瘤病毒感染和宫颈上皮内瘤变患者的局部免疫状态。
Front Immunol. 2021 Jan 20;11:612547. doi: 10.3389/fimmu.2020.612547. eCollection 2020.

引用本文的文献

1
Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3.针对人乳头瘤病毒的口服治疗性疫苗治疗宫颈上皮内瘤变 2 和 3 的 I 期和 II 期随机临床试验。
JNCI Cancer Spectr. 2023 Oct 31;7(6). doi: 10.1093/jncics/pkad101.
2
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing , GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2).一项口服表达HPV16 E7的GLBL101c治疗2级宫颈上皮内瘤变(CIN2)的安慰剂对照、双盲随机(IIB期)试验。
Vaccines (Basel). 2021 Apr 1;9(4):329. doi: 10.3390/vaccines9040329.
3
A prognostic value of CD45RA, CD45RO, CCL20 and CCR6 expressing cells as 'immunoscore' to predict cervical cancer induced by HPV.
CD45RA、CD45RO、CCL20 和 CCR6 表达细胞作为“免疫评分”预测 HPV 诱导宫颈癌的预后价值。
Sci Rep. 2021 Apr 22;11(1):8782. doi: 10.1038/s41598-021-88248-x.
4
Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes.阴茎鳞状细胞癌的人乳头瘤病毒状态与肿瘤浸润性T淋巴细胞的差异相关。
Virchows Arch. 2015 Mar;466(3):323-31. doi: 10.1007/s00428-014-1713-4. Epub 2014 Dec 28.
5
Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein.表达人乳头瘤病毒16 E1蛋白的改良安卡拉痘苗病毒载体的免疫学特性
Clin Vaccine Immunol. 2014 Feb;21(2):147-55. doi: 10.1128/CVI.00678-13. Epub 2013 Dec 4.
6
Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.程序性死亡(PD)-1及其配体 PD-L1 的表达增加与高危型人乳头瘤病毒相关的宫颈上皮内瘤变中的细胞介导免疫受损相关。
Immunology. 2013 Aug;139(4):513-22. doi: 10.1111/imm.12101.
7
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach.治疗性人乳头瘤病毒(HPV)疫苗:一种新方法。
Open Virol J. 2012;6:264-9. doi: 10.2174/1874357901206010264. Epub 2012 Dec 28.